<http://webisa.webdatacommons.org/prov/502659856>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/220375788> .
<http://webisa.webdatacommons.org/prov/193352052>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/220375788> .
<http://webisa.webdatacommons.org/220375788>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<genengnews.com> .
<http://webisa.webdatacommons.org/220375788>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/220375788>	<http://www.w3.org/ns/prov#value>	"To Biogen Idec, Japan is attractive because its healthcare system provides low-cost, universal coverage for patients with diseases for which the company is developing treatments, such as MS and hemophilia." .